Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

February 3, 2017

Conditions
Hypoprothrombinemia
Interventions
OTHER

Warfarin adjustment using the Fearon algorithm

All available historical data will be used to calculate with the Fearon algorithm the individual sensitivity to warfarin and to dose changes as well as lag time until a dose adjustment reaches full effect. Based on this a personal dosing nomogram will be developed and provided to the investigator and to the patients. This nomogram will be used during 6 month but override is possible if the investigator feels that the suggestion from the nomogram is unsafe.

OTHER

Warfarin adjustment using standard dosing

Patients will receive warfarin dosing instructions from a trained nurse using fixed nomograms and computer-based dosing suggestion.

Trial Locations (1)

L8L 2X2

Thrombosis Service, HHS-General Hospital, Hamilton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Epitome Pharmaceuticals

UNKNOWN

lead

McMaster University

OTHER